DÜSSELDORF, GERMANY, 21 November 2023 – Fourier Intelligence, a global leader in rehabilitation and assistive technologies, recently participated in Medica 2023, the world’s leading trade fair for the medical industry. For over four decades, MEDICA has been the largest trade event in the medical sector, bringing exhibitors from more than 50 countries around the globe to showcase the leading innovations and businesses in medical technology, products, devices, and instruments. The event was attended by thousands of national and international leaders, health professionals, and decision-makers.
Actively participating in trade fairs and exhibitions around the globe, Fourier Intelligence is at the forefront of rehabilitation technology by providing solutions for upper, lower, balance and movement solutions that cover the full spectrum of rehabilitation. Throughout the four-day event, Fourier Intelligence unveiled its latest advancements in rehabilitation technologies.
Some key highlights at the exhibition were demonstrations of Fourier Intelligence’s flagship devices, such as the ArmMotus™ EMU and ExoMotus™ M4. The award-winning ArmMotus™ EMU was recently awarded the 2023 IERA Award. Featuring immersive gamified therapy, the ArmMotus™ EMU is designed for upper limb rehabilitation and offers treatment for a wide range of medical conditions. It effectively addresses impairments caused by stroke, traumatic brain injuries, spinal cord injuries, orthopaedic disorders, and other neurological disorders affecting the upper extremities.
In addition, the ExoMotus™ M4, winner of the IF Design Award 2022, focuses on gait training to help individuals regain their mobility and confidence after injuries like stroke, traumatic brain injuries, post-brain surgery, spinal cord injury, and more. With patient safety as a top priority, it is designed to reduce the risk of falls during therapy with its ergonomic balance frame and safety harnesses. It gives patients the confidence to move freely without fear, minimising stress and improving overall outcomes.
“Our participation in Medica 2023 is an excellent platform for Fourier Intelligence to showcase its products to the world. We are committed to driving innovation in the industry through continuous research & development, and our passion for rehabilitation fuels the team to push the limits of rehabilitation technology. We understand the challenges therapists and patients face; thus, we strive to provide the best solutions to combat these and empower them to yield better recovery results,” said Zen Koh, Co-Founder & Global CEO of Fourier Intelligence.
Guided by his leadership, Fourier Intelligence has made remarkable advancements in neurorehabilitation robotics, showcasing an unwavering commitment to delivering top-notch patient care via groundbreaking and innovative rehabilitation technology solutions. With a global presence and over 2,000 installations worldwide, the company is committed to empowering clinicians and patients by providing cutting-edge technology for better outcomes and quality of life.
About Fourier Intelligence
Fourier Intelligence is a leading technology company dedicated to developing exoskeleton and rehabilitation robotics with a focus on creativity since its inception in 2015. The company collaborates with researchers, therapists, and patients to deliver cutting-edge rehabilitation robotics solutions. Fourier Intelligence aims to elevate user experience through its interconnectable intelligent robotics technology, providing an intuitive, easy-to-use system that enhances the lives of both patients and therapists.
For media inquiries, please contact:
Martin OOI, Marketing Manager